Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students, this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.
The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.
Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Vendeur : California Books, Miami, FL, Etats-Unis
Etat : New. N° de réf. du vendeur I-9798906732316
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798906732316
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000. N° de réf. du vendeur L0-9798906732316
Quantité disponible : Plus de 20 disponibles
Vendeur : CitiRetail, Stevenage, Royaume-Uni
Paperback. Etat : new. Paperback. Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students, this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. N° de réf. du vendeur 9798906732316
Quantité disponible : 1 disponible(s)
Vendeur : AussieBookSeller, Truganina, VIC, Australie
Paperback. Etat : new. Paperback. Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students, this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability. N° de réf. du vendeur 9798906732316
Quantité disponible : 1 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Medicines generate their most important evidence after they enter real-world use, where patterns of exposure, treatment outcomes, safety signals and healthcare costs must be interpreted at population level. Written for Pharm.D students , this book develops the principles needed to evaluate medicine use, risk and economic value with methodological and clinical relevance.The pharmacoepidemiology section progresses from outcome and drug-use measures, medication adherence and risk estimation to study designs, drug-utilisation review, meta-analysis, spontaneous reporting, prescription event monitoring and major healthcare data sources. The pharmacoeconomics section examines cost concepts, clinical, economic and humanistic outcomes, QALY and DALY, major economic evaluation methods, ICER, budget impact, formulary decision-making and the use of analytical software and decision models.Worked calculations, synthetic case scenarios, model answers and structured revision material reinforce interpretation rather than formula memorisation. By linking epidemiological reasoning with cost-outcome analysis and formulary decisions, the book supports systematic learning, quantitative competence and the professional judgement required in clinical pharmacy, drug-safety evaluation and healthcare resource allocation. N° de réf. du vendeur 9798906732316
Quantité disponible : 2 disponible(s)
Vendeur : preigu, Osnabrück, Allemagne
Taschenbuch. Etat : Neu. Pharmacoepidemiology and Pharmacoeconomics | Principles, Methods, Calculations and Clinical Applications | Ghosh Payel (u. a.) | Taschenbuch | Englisch | 2026 | Notion Press | EAN 9798906732316 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. N° de réf. du vendeur 136341808
Quantité disponible : 5 disponible(s)